AAAAAA
Results: 76-100/109
Authors:
Wagner, EF
Citation: Ef. Wagner, Mouse models for cancer, EUROCANCER 98, 1998, pp. 251-252
Authors:
Behr, JP
Citation: Jp. Behr, Non-viral gene delivery, EUROCANCER 98, 1998, pp. 255-256
Authors:
Hofmann, C
Huser, A
Lehnert, W
Sandig, V
Jennings, G
Rudolph, M
Brand, K
Strauss, M
Citation: C. Hofmann et al., Baculovirus-based vectors for gene delivery into liver cells, EUROCANCER 98, 1998, pp. 257-258
Authors:
Rommelaere, J
Citation: J. Rommelaere, Parvoviruses and oncotropism, EUROCANCER 98, 1998, pp. 259-259
Authors:
Hatziioannou, T
Lavillette, D
Maurice, M
Valsesia-Wittmann, S
Russell, SJ
Cosset, FL
Citation: T. Hatziioannou et al., Engineering retrovirus particles: targeting viral infection, EUROCANCER 98, 1998, pp. 261-262
Authors:
Hong, SS
Davison, E
Legrand, V
Mehtali, M
Santis, G
Boulanger, P
Citation: Ss. Hong et al., Engineering adenovirus fibers, EUROCANCER 98, 1998, pp. 263-264
Authors:
Brenner, MK
Heslop, HE
Rooney, CM
Citation: Mk. Brenner et al., Gene and cell transfer for specific immunotherapy, EUROCANCER 98, 1998, pp. 267-271
Authors:
Tanaka, T
Cao, Y
Folkman, J
Fine, HA
Citation: T. Tanaka et al., Targetted anti-angiogenesis: viral vectors encoding peptides that inhibit angiogenesis as a novel gene therapy strategy for locally invasive tumors, EUROCANCER 98, 1998, pp. 275-276
Authors:
Collard, JG
Citation: Jg. Collard, Rho-like GTPases: their role in invasion of epithelial tumor cells, EUROCANCER 98, 1998, pp. 277-278
Authors:
Greenberg, P
Gilbert, M
Nelson, B
Lord, J
Kalos, M
Riddell, S
Citation: P. Greenberg et al., Manipulating effector T cells, EUROCANCER 98, 1998, pp. 281-282
Authors:
Patterson, AV
Stratford, IJ
Citation: Av. Patterson et Ij. Stratford, Exploiting tumour-specific physiology to target redox-dependent molecular chemotherapy, EUROCANCER 98, 1998, pp. 285-287
Authors:
Zitvogel, L
Fernandez, N
Lozier, A
Wolfers, J
Merad, M
Angevin, E
Amigorena, S
Escudier, B
Citation: L. Zitvogel et al., Immunotherapy for cancer by dendritic cell therapy - From preclinical bases to therapeutic trial designs, EUROCANCER 98, 1998, pp. 289-291
Authors:
Cohen-Haguenauer, O
Masset, M
Carteau, AE
Setterblad, N
Kazal, I
Bedel, JF
Demerens, C
Dal Cortivo, L
Marolleau, JP
Benbunan, M
Boiron, M
Peault, B
Marty, M
Citation: O. Cohen-haguenauer et al., A novel retrovirus vector derived from Fr-MuLV FB29 mediating transductionof haematopoietic cells, EUROCANCER 98, 1998, pp. 293-294
Authors:
Dranoff, G
Citation: G. Dranoff, Granulocyte-macrophage colony stimulating factor based cancer vaccines, EUROCANCER 98, 1998, pp. 297-298
Authors:
Parmiani, G
Citation: G. Parmiani, Gene modified human melanoma cell vaccines: new strategies, EUROCANCER 98, 1998, pp. 299-299
Authors:
Ram, Z
Citation: Z. Ram, Retroviral-mediated gene transfer in brain tumors. Clinical experience andfuture perspectives, EUROCANCER 98, 1998, pp. 301-302
Authors:
Gunzburg, WH
Karle, P
Muller, P
Saller, RM
Liebe, S
Lohr, JM
Salmons, B
Citation: Wh. Gunzburg et al., New strategies for treatment of pancreatic cancer: cell therapy and gene therapy, EUROCANCER 98, 1998, pp. 303-304
Authors:
Zalcman, G
Citation: G. Zalcman, Biological advances in non-small-cell lung cancer - Prognostic and therapeutic implications, EUROCANCER 98, 1998, pp. 307-309
Authors:
Grunenwald, D
Citation: D. Grunenwald, Surgical staging in non-small-cell lung cancer?, EUROCANCER 98, 1998, pp. 311-316
Authors:
Le Chevalier, T
Citation: T. Le Chevalier, Chemotherapy of evolved non-small-cell lung cancer, EUROCANCER 98, 1998, pp. 317-318
Authors:
Bokemeyer, C
Harstrick, A
Beyer, J
Metzner, B
Ruther, U
Hartmann, JT
Holstein, K
Derig, HG
De Wit, R
Casper, J
Schoffski, P
Kuhrer, I
Illiger, HJ
Kempf, B
Reichle, A
Foller, A
Hossfeld, DK
Fischer, JT
Berdel, WE
Gerhartz, HH
Kirchner, H
Pfluger, KH
Ostermann, H
Kanz, L
Schmoll, HJ
Citation: C. Bokemeyer et al., The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors, EUROCANCER 98, 1998, pp. 321-323
Authors:
Droz, JP
Teillac, P
Citation: Jp. Droz et P. Teillac, Urological cancer: introduction, EUROCANCER 98, 1998, pp. 327-328
Authors:
Latil, A
Cussenot, O
Citation: A. Latil et O. Cussenot, Predisposition and susceptibility to prostate cancer (polymorphisms and germ-cell mutations), EUROCANCER 98, 1998, pp. 329-332
Authors:
Pommier, P
Citation: P. Pommier, Treatment of localized cancer of the prostate, EUROCANCER 98, 1998, pp. 333-334
Authors:
Mottet, N
Citation: N. Mottet, Localized cancer of the prostate, EUROCANCER 98, 1998, pp. 335-336